Specialty and generic pharmaceutical company; injectable, inhalation & other products
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2017 | VENABLE LLP |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Termination (No Activity) |
— | |
| 2017 | VENABLE LLP |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2017 | VENABLE LLP |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2017 | VENABLE LLP |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2016 | VENABLE LLP |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2016 | VENABLE LLP |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2016 | VENABLE LLP |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2016 | VENABLE LLP |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2015 | VENABLE LLP |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2015 | VENABLE LLP |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— |
| Firm | Filings | Expenses |
|---|---|---|
| VENABLE LLP | 25 | — |
| Issue | Activities |
|---|---|
| Health Issues | 17 |
| Medical/Disease Research/Clinical Labs | 6 |